US 10010524
Short acting phenylalkylamine calcium channel blockers and uses thereof
granted A61KA61K31/216A61K31/26
Quick answer
US patent 10010524 (Short acting phenylalkylamine calcium channel blockers and uses thereof) held by Milestone Pharmaceuticals Inc. expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Milestone Pharmaceuticals Inc.
- Grant date
- Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/216, A61K31/26, A61K31/275, A61K31/277